Given the prevalence and potentially pivotal nature of these mutations in the etiology of the disease, we sought to define transcriptional patterns associated with p53 mutational status in a series of early and advanced serous ovarian cancers. This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.